This study illustrates that, even though the expression of the classical activation markers CD11b and CD62L is normally regulated, mature neutrophils in COVID-19 patients remain partially refractory to activation by damage associated molecular patterns such as mitochondrial derived formyl-peptides. This evidence concerns the gene SELL and COVID-19.